HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
1.100
-0.080 (-6.78%)
Mar 31, 2025, 10:49 AM EDT - Market open
HOOKIPA Pharma Stock Forecast
HOOK's stock price has decreased by -83.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for HOOKIPA Pharma stock have an average target of 10.67, with a low estimate of 2.00 and a high estimate of 23. The average target predicts an increase of 870.00% from the current stock price of 1.10.
Analyst Consensus: Buy
* Price targets were last updated on Dec 20, 2024.
Analyst Ratings
The average analyst rating for HOOKIPA Pharma stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 0 | 0 | 0 |
| Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 10, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $48 → $2 | Buy → Hold | Downgrades | $48 → $2 | +81.82% | Dec 20, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $24 → $7 | Buy | Maintains | $24 → $7 | +536.36% | Nov 21, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $50 → $48 | Buy | Maintains | $50 → $48 | +4,263.64% | Nov 15, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $23 → $24 | Buy | Maintains | $23 → $24 | +2,081.82% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
19.64M
from 43.95M
Decreased by -55.32%
Revenue Next Year
1.02M
from 19.64M
Decreased by -94.81%
EPS This Year
-2.20
from -3.47
EPS Next Year
-1.47
from -2.20
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.3M | 1.1M | 10.5M | ||
| Avg | 19.6M | 1.0M | 10.2M | ||
| Low | 13.2M | 980,000 | 9.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -40.3% | -94.7% | 929.4% | ||
| Avg | -55.3% | -94.8% | 900.0% | ||
| Low | -69.9% | -95.0% | 860.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.99 | -1.39 | -4.31 | ||
| Avg | -2.20 | -1.47 | -4.18 | ||
| Low | -2.55 | -1.53 | -4.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.